AVITA Medical, Inc. (RCEL)
15.63
-0.57
(-3.52%)
USD |
NASDAQ |
Nov 13, 16:00
15.60
-0.03
(-0.19%)
After-Hours: 19:59
AVITA Medical Total Liabilities (Quarterly) : 77.83M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 77.83M |
| June 30, 2026 | 75.62M |
| March 31, 2026 | 74.71M |
| December 31, 2025 | 69.34M |
| September 30, 2025 | 66.31M |
| June 30, 2025 | 67.18M |
| March 31, 2025 | 70.40M |
| December 31, 2024 | 72.00M |
| September 30, 2024 | 65.86M |
| June 30, 2024 | 60.36M |
| March 31, 2024 | 60.07M |
| December 31, 2023 | 58.23M |
| Date | Value |
|---|---|
| September 30, 2023 | 14.05M |
| June 30, 2023 | 15.23M |
| March 31, 2023 | 13.10M |
| December 31, 2022 | 11.70M |
| September 30, 2022 | 10.66M |
| June 30, 2022 | 9.946M |
| March 31, 2022 | 8.676M |
| June 30, 2021 | 9.846M |
| March 31, 2021 | 9.144M |
| December 31, 2020 | 9.708M |
| September 30, 2020 | 9.931M |
| June 30, 2020 | 10.06M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Iovance Biotherapeutics, Inc. | 178.55M |
| Halozyme Therapeutics, Inc. | 3.529B |
| Agenus, Inc. | 357.70M |
| Amgen, Inc. | 81.70B |
| Fate Therapeutics, Inc. | 105.24M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 46.79M |
| Shareholders Equity (Quarterly) | -31.04M |
| Debt to Equity Ratio | -1.519 |
| Current Ratio | 1.201 |
| Net Debt Paydown Yield | -0.14% |